MTOR and hepatocellular carcinoma: To further investigate whether circRNA‐mTOR affects HCC progression and lenvatinib resistance by interacting with PSIP1, rescue experiments were conducted by interfering with PSIP1 expression in HCC cells that stably overexpressed circRNA‐mTOR.